Elderly physician leaves Amita Health after refusing to learn new EMR system

Jeffrey Johnson, MD, a 75-year-old physician, and Amita Health St. Alexius Medical Center have parted ways after Johnson refused to take educational courses on the hospital's new electronic medical record (EMR) system.

Following the implementation of the new EMR, Johnson refused to take classes on how to properly use the computer system. "I just can't practice anymore at our hospital because I don't know how to use the computer efficiently,” said Johnson.

"Our hospital recently implemented a new electronic-medical-record (EMR) platform as part of a systemwide initiative to ensure that patient records are readily accessible and shared on a common platform across all our facilities," said Len Wilk, president and CEO of Amita Health St. Alexius Medical Center. "EMR technology has been shown to reduce medical errors and increase quality and safety. Because Amita Health is committed to delivering the highest-quality care and ensuring patient safety, we require all of our practitioners to receive training in the use of our new EMR platform for ordering and documenting clinical care."

Johnson, estimated to have delivered around 15,000 babies, will continue to see women in his private practice to confirm pregnancy and refer patients to either his son or brother, both obstetricians.

Read the full story below:

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

A string of executive orders from the White House created serious concerns among radiologists and other healthcare providers throughout the United States. The American College of Radiology issued a statement to help guide its members through the chaos. 

Bridgefield Capital, founded in 2015, has previously invested in such popular brands as Cirque Du Soleil, Del Monte and Quiksilver. This transaction is expected to be completed in the second half of 2025. 

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it.